People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Other Health Care, Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Somatus, Inc. | — | Other Health Care | Series C | $140.1M | $1.1B | 2017 |
| Solera Health, Inc. | — | Healthtech | Series B | $79.1M | $935.6M | 2018 |
| PWN Health Holdings, Inc. | — | Healthtech | Series C | $61.8M | $1.5B | 2020 |
| higi SH Holdings Inc. | — | Other | Series B | $55.2M | $521.9M | 2018 |
| Sevaro Health Inc | — | Healthtech | Series B | $46.0M | $175.0M | 2025 |
| Change Healthcare Corp | — | Other Health Care | Series B | $45.6M | $110.8M | 2013 |
| Axial Healthcare Holdings, L.P. | — | Healthtech | Series C | $45.0M | $408.6M | 2024 |
| Jukebox Health Inc. | — | Healthtech | Series B | $25.7M | $117.7M | 2025 |
| Axial Healthcare, Inc. | — | Healthtech | Series B | $25.5M | $422.3M | 2014 |
| Contessa Health, Inc. | — | Healthtech | Series A | $10.5M | $158.0M | 2015 |
| Journey Health Inc. | — | Healthtech | Seed | $1.3M | $34.7M | 2019 |
Anna Haghgooie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anna Haghgooie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Liam Donohue | 2 | 12 |
| Michael Greeley | 1 | 15 |
| Rick Smith | 1 | 14 |
| Glen Tullman | 1 | 12 |
| John Collins | 1 | 9 |
| Vic Gatto | 1 | 9 |
| Enrico Picozza | 1 | 7 |
| Julian Harris | 1 | 6 |
| Matthew Downs | 1 | 5 |
| Tracy Bahl | 1 | 5 |
| Nancy Brown | 1 | 5 |
| Cody Nystrom | 1 | 5 |
| David Whelan | 1 | 5 |
| Martin Felsenthal | 1 | 5 |
| Patrick Kennedy | 1 | 4 |
| Spence McClelland | 1 | 4 |
| Trevor Price | 1 | 4 |
| John Donahue | 1 | 4 |
| Lawrence Leisure | 1 | 4 |
| Peter Neupert | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.